# The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia

> **NCT02274051** · PHASE1 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 15 (actual)

## Conditions studied

- Familial Dysautonomia

## Interventions

- **DIETARY_SUPPLEMENT:** Kinetin

## Key facts

- **NCT ID:** NCT02274051
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2019-05-04
- **Final completion:** 2019-05-04
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02274051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02274051, "The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02274051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*